Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Chronic PeriodontitisEnd Stage Renal Disease
Interventions
OTHER

Test

Briefly, treatment sessions will include oral hygiene behavioral modification and scaling and root planning (removing the bacterial biofilm and calculus below the gum line) in order to eliminate etiologic factors and control periodontal inflammation. Once the treatment sessions are completed, the patients will enter the maintenance phase and will be followed for 6 months. In this phase, the patients will receive systematic supportive periodontal treatment (tooth cleanings above the gum line with re-enforcement of oral hygiene).

Trial Locations (1)

06030-1710

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

UConn Health

OTHER

NCT03241511 - Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial | Biotech Hunter | Biotech Hunter